Back to comparisons

Comparison

Curcumin (Turmeric) vs Memantine (Namenda)

FieldCurcumin (Turmeric)Memantine (Namenda)
Categoryneuroprotectiveneuroprotective
Dose range500–2000mg5–20mg
Half-life70h
Onset180min
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●
Legal (US)USOTCUSRx
PubMed refs140004200

The comparison in plain English

Auto-generated from data

Curcumin (Turmeric) and Memantine (Namenda) are both in the neuroprotective category respectively. Curcumin (Turmeric) Yellow pigment of turmeric root. Memantine (Namenda) Prescription NMDA receptor antagonist for moderate-to-severe Alzheimer's disease.

Bottom line

Curcumin (Turmeric) (evidence B, safety 5/5) has a stronger evidence base than Memantine (Namenda) (evidence A, safety 4/5). Curcumin (Turmeric) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Curcumin (Turmeric) if

Curcumin (Turmeric) is the better fit when your goal aligns with its mechanism (Inhibits NF-κB transcription factor activation, suppressing dozens of downstream pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)) and the dose range (500–2000mg) suits your protocol. Half-life is –h.

Choose Memantine (Namenda) if

Memantine (Namenda) is the better fit when your goal aligns with its mechanism (Uncompetitive NMDA receptor antagonist, blocks the NMDA channel only when it's pathologically over-activated, sparing normal signaling) and the dose range (5–20mg) suits your protocol. Half-life is 70h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →